Wealthspire Advisors (Maryland)’s Galmed Pharmaceuticals GLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75	Closed	-$65K	–	503
2019 Q3	$65K	Buy	+75	New	+$65K	﹤0.01%	456